Sens. Collins, Lujan Introduce Bill to Spur Research on Neurological Diseases Like Alzheimer's
December 21, 2021
December 21, 2021
WASHINGTON, Dec. 21 -- Sen. Susan M. Collins, R-Maine, issued the following news release:
In a bipartisan effort to accelerate the prevention, treatment, and cure of neurological diseases, U.S. Senators Susan Collins (R-ME) and Ben Ray Lujan (D-NM) introduced the Neuroscience Center of Excellence Act. The legislation would establish a Neuroscience Center of Excellence at the Food and Drug Administration (FDA) and is modeled after the FDA's successful Oncology Center of Excellen . . .
In a bipartisan effort to accelerate the prevention, treatment, and cure of neurological diseases, U.S. Senators Susan Collins (R-ME) and Ben Ray Lujan (D-NM) introduced the Neuroscience Center of Excellence Act. The legislation would establish a Neuroscience Center of Excellence at the Food and Drug Administration (FDA) and is modeled after the FDA's successful Oncology Center of Excellen . . .